Posted On: 03/09/2016 7:36:45 PM
Post# of 30066
Quote:
We anticipate another Orphan Drug application to go under review for Wolfram s Syndrome in the near future.
http://s1.q4cdn.com/460208960/files/March-8-2...S_Zeng.pdf
Why THI brings the value:
Quote:
The combined company will offer cutting edge pharma services in the
areas of cell cycle biology and signal transduction pathways to assist
pharmaceutical companies and medical researchers in identifying
treatment pathways for disease.
http://content.stockpr.com/amarantus/db/184/1...+FINAL.pdf
(2)
(1)
